What is a stock summary page? Click here for an overview.
Business Description
Escalon Medical Corp
NAICS : 334510
SIC : 3845
ISIN : US2960743050
Description
Escalon Medical Corp operates in the healthcare market specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.58 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 1.32 | |||||
| Interest Coverage | 10.5 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -17.62 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.6 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year Book Growth Rate | 12.6 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.5 | |||||
| 9-Day RSI | 21.67 | |||||
| 14-Day RSI | 32.02 | |||||
| 3-1 Month Momentum % | 56.64 | |||||
| 6-1 Month Momentum % | 66.37 | |||||
| 12-1 Month Momentum % | -23.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.95 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 89.73 | |||||
| Days Sales Outstanding | 53.56 | |||||
| Days Payable | 61.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 32.08 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.17 | |||||
| Operating Margin % | 1.73 | |||||
| Net Margin % | 1.53 | |||||
| FCF Margin % | 1.39 | |||||
| ROE % | 10.2 | |||||
| ROA % | 4 | |||||
| ROIC % | 8.46 | |||||
| 3-Year ROIIC % | 49.3 | |||||
| ROC (Joel Greenblatt) % | 11.08 | |||||
| ROCE % | 9.73 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.53 | |||||
| PE Ratio without NRI | 15.53 | |||||
| PS Ratio | 0.11 | |||||
| PB Ratio | 0.83 | |||||
| Price-to-Tangible-Book | 0.86 | |||||
| Price-to-Free-Cash-Flow | 51.75 | |||||
| Price-to-Operating-Cash-Flow | 51.75 | |||||
| EV-to-EBIT | 7.83 | |||||
| EV-to-EBITDA | 6.42 | |||||
| EV-to-Revenue | 0.13 | |||||
| EV-to-FCF | 9.5 | |||||
| Price-to-GF-Value | 1.11 | |||||
| Price-to-Projected-FCF | 7.76 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Graham-Number | 0.78 | |||||
| Price-to-Net-Current-Asset-Value | 0.97 | |||||
| Earnings Yield (Greenblatt) % | 12.77 | |||||
| FCF Yield % | 14.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ESMC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Escalon Medical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.17 | ||
| EPS (TTM) ($) | 0.01 | ||
| Beta | 0.33 | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 1.91 | ||
| Volatility % | 65.74 | ||
| 14-Day RSI | 32.02 | ||
| 14-Day ATR ($) | 0.004573 | ||
| 20-Day SMA ($) | 0.183013 | ||
| 12-1 Month Momentum % | -23.39 | ||
| 52-Week Range ($) | 0.1058 - 0.247 | ||
| Shares Outstanding (Mil) | 7.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Escalon Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Escalon Medical Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Escalon Medical Corp Frequently Asked Questions
What is Escalon Medical Corp(ESMC)'s stock price today?
The current price of ESMC is $0.16. The 52 week high of ESMC is $0.25 and 52 week low is $0.11.
When is next earnings date of Escalon Medical Corp(ESMC)?
The next earnings date of Escalon Medical Corp(ESMC) is .
Does Escalon Medical Corp(ESMC) pay dividends? If so, how much?
Escalon Medical Corp(ESMC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers